SELLAS Life Sciences Group Dividend
Dividend criteria checks 0/6
SELLAS Life Sciences Group no tiene antecedentes de pago de dividendos.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$0.66 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To Spend Its Cash Wisely
Jul 13
SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To Spend Its Cash Wisely
Sep 20SELLAS Life Sciences rises 9% after cancer drug shows promising result in animal study
Aug 09We Think SELLAS Life Sciences Group (NASDAQ:SLS) Needs To Drive Business Growth Carefully
Mar 08Is SELLAS Life Sciences Group (NASDAQ:SLS) In A Good Position To Invest In Growth?
Nov 23Companies Like SELLAS Life Sciences Group (NASDAQ:SLS) Are In A Position To Invest In Growth
Jul 19SELLAS Life Sciences updates on at-the-market offering
Jun 02SELLAS Life Sciences jumps 43% after Reddit mentions
Feb 03Sellas' galinpepimut-S combo shows promising action in early-stage solid tumor studies
Dec 21Sellas Life Sciences strengthens balance sheet with addition of $30.5M
Dec 17Sellas Life Sciences prices $16.2M direct offering
Dec 14Nelipepimut-S data from breast cancer study fails to lift SELLAS Life Sciences
Dec 11SELLAS and 3D Medicines in exclusive license agreement for development and commercialization of GPS and GPS+ in Greater China
Dec 07SELLAS Life Sciences EPS misses by $0.26
Nov 13Stability and Growth of Payments
Fetching dividends data
Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de SLS han sido estables en el pasado.
Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de SLS han aumentado.
Dividend Yield vs Market
| SELLAS Life Sciences Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (SLS) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Biotechs) | 2.8% |
| Analyst forecast in 3 Years (SLS) | n/a |
Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de SLS en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.
Alto dividendo: No es posible evaluar la rentabilidad por dividendo de SLS en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.
Earnings Payout to Shareholders
Cobertura de los beneficios: No hay datos suficientes para calcular el ratio de reparto de SLS para determinar si sus dividendos están cubiertos por los beneficios.
Cash Payout to Shareholders
Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que SLS no ha comunicado ningún pago.